Methods and systems for detecting a bioactive agent effect

• US 20090271215A1
• Filed: 09/12/2008
• Published: 10/29/2009
• Est. Priority Date: 04/24/2008
• Status: Active Grant

• Current Assignee: Harvest Bio LLC
• Original Assignee: Searete LLC (Intellectual Ventures LLC)
• Inventors: Ishikawa, Muriel Y., Lord, Robert W., Levien, Royce A., Wood, Lowell L. JR., Hyde, Roderick A., Malamud, Mark A., Sweeney, Elizabeth A., Wood, Victoria Y.H., Leuthardt, Eric C.
• Granted Patent: US 8,930,208 B2
• Time in Patent Office: Days
• US Class Current: 705/2
• CPC Class Codes: G06Q 10/00 Administration; Management
• CPC Class Codes: G06Q 50/22 Social work or social welfare, e.g. community support activities or counselling services
• CPC Class Codes: G16H 20/10 relating to drugs or medications, e.g. for ensuring correct administration to patients
• CPC Class Codes: G16H 40/67 for remote operation

Abstract

Methods, computer program products, and systems are described that include accepting at least one indication of bioactive agent use by an individual and/or presenting an indication of an artificial sensory experience programmed to detect at least one effect of the bioactive agent at least partly based on the at least one indication of the bioactive agent.

Claims

1. A computer-implemented method, comprising:

accepting at least one indication of bioactive agent use by an individual; and

presenting an indication of an artificial sensory experience programmed to detect at least one effect of the bioactive agent at least partly based on the at least one indication of the bioactive agent.

2-30. -30. (canceled)

31. A system, comprising:

means for accepting at least one indication of bioactive agent use by an individual; and

means for presenting an indication of an artificial sensory experience programmed to detect at least one effect of the bioactive agent at least partly based on the at least one indication of the bioactive agent.

32. The system of claim 31, wherein the means for accepting at least one indication of bioactive agent use by an individual comprises:

means for accepting an identification of at least one bioactive agent prescribed for the individual.

33. The system of claim 32, wherein the means for accepting an identification of at least one bioactive agent prescribed for the individual comprises:

means for accepting an identification of at least one of an anti-depressant, an anxiolytic medication, a pain medication, a behavior modifying medication, a weight adjustment drug, an anti-Alzheimer'"'"'s medication, or an anti-stroke medication as the at least one bioactive agent.

34. The system of claim 31, wherein the means for accepting at least one indication of bioactive agent use by an individual comprises:

means for accepting an indication of a substance subject to abuse used by the individual.

35. The system of claim 34, wherein the means for accepting an indication of a substance subject to abuse used by the individual comprises:

means for accepting an indication of at least one of alcohol use, psychoactive drug use, tranquilizer abuse, methamphetamine use, tobacco use, marijuana use, or narcotic use.

36. The system of claim 31, wherein the means for accepting at least one indication of bioactive agent use by an individual comprises:

means for accepting an indication of nutraceutical use by the individual.

37. The system of claim 36, wherein the means for accepting an indication of nutraceutical use by the individual comprises:

means for accepting an indication of at least one of a memory supplement, an anti-oxidant, a cancer preventative, a weight adjustment agent, or a mood-changing agent.

38. The system of claim 31, wherein the means for accepting at least one indication of bioactive agent use by an individual comprises:

means for accepting an indication of bioactive agent use by at least one of a computer game participant, a social networking tool user, a virtual world participant, an online student, an online medical information user, or an on-line shopper.

39. The system of claim 31, wherein the means for accepting at least one indication of bioactive agent use by an individual comprises:

means for accepting an indication of bioactive agent use by an individual not previously associated with an artificial sensory experience.

40. The system of claim 31, wherein means for presenting an indication of an artificial sensory experience programmed to detect at least one effect of the bioactive agent at least partly based on the at least one indication of the bioactive agent comprises:

means for presenting an indication of an artificial sensory experience programmed to continuously monitor at least one effect of at least one bioactive agent.

41. The system of claim 31, wherein means for presenting an indication of an artificial sensory experience programmed to detect at least one effect of the bioactive agent at least partly based on the at least one indication of the bioactive agent comprises:

means for presenting an indication of an artificial sensory experience programmed to monitor at least one effect of at least one bioactive agent during at least one specified time interval.

42. The system of claim 31, wherein means for presenting an indication of an artificial sensory experience programmed to detect at least one effect of the bioactive agent at least partly based on the at least one indication of the bioactive agent comprises:

means for presenting an indication of an artificial sensory experience programmed to monitor at least one effect of at least one bioactive agent at a discrete time.

43. The system of claim 31, wherein means for presenting an indication of an artificial sensory experience programmed to detect at least one effect of the bioactive agent at least partly based on the at least one indication of the bioactive agent comprises:

means for monitoring at least one effect of the bioactive agent in near real time.

44. The system of claim 31, wherein means for presenting an indication of an artificial sensory experience programmed to detect at least one effect of the bioactive agent at least partly based on the at least one indication of the bioactive agent comprises:

means for presenting an indication of an artificial sensory experience programmed to measure a physiologic characteristic of the individual.

45. The system of claim 44, wherein means for presenting an indication of an artificial sensory experience programmed to measure a physiologic characteristic of the individual comprises:

means for monitoring at least one of physical activity, body weight, body mass index number, heart rate, blood oxygen level, or blood pressure proximate to administration of the bioactive agent.

46. The system of claim 44, wherein means for presenting an indication of an artificial sensory experience programmed to measure a physiologic characteristic of the individual comprises:

means for monitoring at least one of physical activity, body weight, body mass index number, heart rate, blood oxygen level, or blood pressure associated with bioavailability of the bioactive agent.

47. The system of claim 44, wherein means for presenting an indication of an artificial sensory experience programmed to measure a physiologic characteristic of the individual comprises:

means for monitoring at least one of physical activity, body weight, body mass index number, heart rate, blood oxygen level, or blood pressure temporally associated with the bioactive agent.

48. The system of claim 31, wherein means for presenting an indication of an artificial sensory experience programmed to detect at least one effect of the bioactive agent at least partly based on the at least one indication of the bioactive agent comprises:

means for monitoring at least one neurophysiological activity.

49. The system of claim 31, wherein means for presenting an indication of an artificial sensory experience programmed to detect at least one effect of the bioactive agent at least partly based on the at least one indication of the bioactive agent comprises:

means for utilizing an algorithm configured for detecting at least one effect of the bioactive agent.

50. The system of claim 49, wherein means for utilizing an algorithm configured for detecting at least one effect of the bioactive agent comprises:

means for utilizing an algorithm configured to detect frequency of body movement.

51. The system of claim 49, wherein means for utilizing an algorithm configured for detecting at least one effect of the bioactive agent comprises:

means for utilizing an algorithm configured to detect startle state based on physiological signals.

52. The system of claim 31, wherein means for presenting an indication of an artificial sensory experience programmed to detect at least one effect of the bioactive agent at least partly based on the at least one indication of the bioactive agent comprises:

means for presenting an indication of an artificial sensory experience configured to link at least one of a predetermined behavior or a predetermined action to at least one effect of the bioactive agent.

53. The system of claim 31, wherein means for presenting an indication of an artificial sensory experience programmed to detect at least one effect of the bioactive agent at least partly based on the at least one indication of the bioactive agent comprises:

means for presenting an indication of a modified combined bioactive agent and artificial sensory experience at least partially based on a modified at least one bioactive agent or artificial sensory experience.

54. The system of claim 53, wherein the means for presenting an indication of a modified combined bioactive agent and artificial sensory experience at least partially based on a modified at least one bioactive agent or artificial sensory experience comprises:

means for presenting to at least one output device.

55. The system of claim 54, wherein the means for presenting to at least one output device comprises:

means for presenting to at least one user interface.

56. The system of claim 54, wherein the means for presenting to at least one output device comprises:

means for presenting to at least one mobile device.

57. The system of claim 53, wherein the means for presenting an indication of a modified combined bioactive agent and artificial sensory experience at least partially based on a modified at least one bioactive agent or artificial sensory experience comprises:

means for presenting to a third party.

58. The system of claim 57, wherein the means for presenting to a third party comprises:

means for presenting to a health care provider.

59. The system of claim 57, wherein the means for presenting to a third party comprises:

means for selectively presenting only to the individual.

60. The system of claim 31, wherein means for accepting at least one indication of bioactive agent use by an individual and means for presenting an indication of an artificial sensory experience programmed to detect at least one effect of the bioactive agent at least partly based on the at least one indication of the bioactive agent comprises:

means for accepting an indication of an antidepressant and presenting a virtual world programmed to detect an increase in avatar activity indicating efficacy of the antidepressant.

61. A system, comprising:

circuitry for accepting at least one indication of bioactive agent use by an individual;

circuitry for presenting an indication of an artificial sensory experience programmed to detect at least one effect of the bioactive agent at least partly based on the at least one indication of the bioactive agent.

62. A computer program product comprising:

a signal-bearing medium bearing

one or more instructions for accepting at least one indication of bioactive agent use by an individual; and

one or more instructions for presenting an indication of an artificial sensory experience programmed to detect at least one effect of the bioactive agent at least partly based on the at least one indication of the bioactive agent.

63. The computer program product of claim 62, wherein the signal-bearing medium includes a computer-readable medium.

64. The computer program product of claim 62, wherein the signal-bearing medium includes a recordable medium.

65. The computer program product of claim 62, wherein the signal-bearing medium includes a communications medium.

66. A system comprising:

a computing device; and

instructions that when executed on the computing device cause the computing device to accept at least one indication of bioactive agent use by an individual; and

present an indication of an artificial sensory experience programmed to detect at least one effect of the bioactive agent at least partly based on the at least one indication of the bioactive agent.

67. The system of claim 66 wherein the computing device comprises:

one or more of a personal digital assistant (PDA), a personal entertainment device, a mobile phone, a laptop computer, a tablet personal computer, a networked computer, a computing system comprised of a cluster of processors, a computing system comprised of a cluster of servers, a workstation computer, and/or a desktop computer.

68. The system of claim 66, wherein the computing device is operable to accept the at least one attribute of the at least one individual and present the indication of the at least one prescription medication and the at least one artificial sensory experience from at least one memory.